Horizon Pharma - About the company
Horizon Pharma is a public company based in Dublin (Ireland), founded in 2005. It operates as a Developer of medicines for oncology, inflammation, rare diseases, and general medicine. Horizon Pharma has raised $75M in funding. The company has 1715 active competitors, including 84 funded and 177 that have exited. Its top competitors include companies like AbbVie, Amgen and Gilead.
Company Details
Developer of medicines for oncology, inflammation, rare diseases, and general medicine. The company focuses on leveraging biology and technology to discover new therapies. It manufactures medicines through complex processes involving living cells. The organization invests in research and development to create medicines for serious illnesses.
Key Metrics
Founded Year
2005
Location
Dublin, Ireland
Stage
Public
Total Funding
Investors
Ranked
101st among 1715 active competitors
Employee Count
22 as on May 31, 2026
Exit Details
Public
Sign up to download Horizon Pharma's company profile
Horizon Pharma's funding and investors
Horizon Pharma has raised a total funding of $75M. Horizon Pharma has 9 institutional investors.
View details of Horizon Pharma's funding rounds and investors
Horizon Pharma's founders and board of directors
Founder? Claim ProfileHorizon Pharma's employee count trend
Horizon Pharma has 22 employees as of May 26. Here is Horizon Pharma's employee count trend over the years:
Uncover Horizon Pharma's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Horizon Pharma's Competitors and alternates
Top competitors of Horizon Pharma include AbbVie, Amgen and Gilead. Here is the list of Top 10 competitors of Horizon Pharma, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | $14.7B | 81/100 | |
2nd | Amgen 1980, Thousand Oaks (United States), Public | Developer of pharmaceutical products for treating multiple diseases | - | 81/100 | |
3rd | Gilead 1987, Foster City (United States), Acquired | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | 80/100 | |
4th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | 79/100 | |
5th |  Johnson & Johnson 1886, New Brunswick (United States), Public | Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products | - | 76/100 | |
6th |  AstraZeneca 1999, Cambridge (United Kingdom), Public | Developer of pharmaceutical medicines for oncology and various chronic diseases | - | 73/100 | |
7th |  Roivant Sciences 2014, New York City (United States), Public | Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases | $1.3B | 72/100 | |
8th |  Regeneron Pharmaceuticals 1988, Tarrytown (United States), Public | Developer of antibodies for the treatment of cancer, eye diseases, inflammatory diseases & others | - | 71/100 | |
9th | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 71/100 | |
10th |  Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 70/100 | |
101st |  Horizon Pharma 2005, Dublin (Ireland), Public | Developer of medicines for oncology, inflammation, rare diseases, and general medicine | $75M | 45/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Horizon Pharma's competitors? Click here to see the top ones
Horizon Pharma's Investments and acquisitions
Horizon Pharma has made no investments or acquisitions yet.
News related to Horizon Pharma
Filter this list•
Top-Rated Pharma Stock Nears Breakout After Earnings Trounce ViewsInvestor's Business Daily•May 08, 2019•Horizon Pharma
•
•
•
•
•
Horizon Pharma plc Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire•Apr 04, 2019•Horizon Pharma
•
•
•
Ireland’s Horizon Pharma To Raise $284 Mln In Underwritten Public OfferingInvestsize•Mar 07, 2019•Horizon Pharma
•
No. 1 Pharma Stock Dives As DOJ Investigates Potential KickbacksInvestor's Business Daily•Mar 06, 2019•Horizon Pharma
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Horizon Pharma
Explore our recently published companies
- Wisdom Square Technologies - New Hyde Park based, 2008 founded, Unfunded company
- Fruverpack - Almoradi based, 1992 founded, Unfunded company
- AERA - Bouxwiller based, 1979 founded, Unfunded company
- Divine Hindu - Ujjain based, 2023 founded, Unfunded company
- Globaldigitalpartner.com - 2013 founded, Unfunded company
- OROK - Bourgoin Jallieu based, 2018 founded, Deadpooled company
